Viewing nowSelmetec Tablet 20 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201503645 · Approved 2015.06.08 · Insurance code 693901510
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure remains persistently high, and this medication is used to treat essential hypertension. It effectively controls blood pressure, reducing the risk of cardiovascular diseases and improving overall health.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect occurs within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this drug is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy or safety of this drug have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg once daily. Use in patients with severe hepatic impairment is not recommended, as there is no experience with its use in these patients.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn during pregnancy, especially in the 2nd and 3rd trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to any ingredient in this medication, pregnant or breastfeeding women, patients on dialysis, patients with severe liver impairment, and patients with bile duct obstruction should not use this medication. Patients with low blood volume or low salt levels may experience low blood pressure, so their condition should be closely monitored before administration. Patients with severe heart failure or reduced kidney function should use this medication carefully as there is a risk of worsening kidney function. Patients with weak kidney function should have their potassium and creatinine levels checked regularly, and it is not recommended for patients with severe kidney impairment. Patients with certain heart diseases or primary aldosteronism also require special caution when using this medication. As this medication lowers blood pressure, dizziness may occur, so avoid driving or operating hazardous machinery carefully. While taking this medication, side effects such as dizziness, headache, abdominal pain, muscle pain may occur, and rarely face swelling or angioedema can occur. Long-term use may lead to liver dysfunction or autoimmune hepatitis, so consult a doctor immediately if any unusual symptoms arise. Caution is required when taking this medication with other antihypertensives, potassium-sparing diuretics, or potassium supplements as it can lead to increased blood potassium levels. Taking with non-steroidal anti-inflammatory drugs can worsen kidney function; thus, renal function should be monitored regularly. Combination with lithium may increase lithium levels, leading to toxicity; therefore, it is not recommended to be taken together. Discontinuation of this medication is necessary during pregnancy due to the risk of serious fetal damage, and women who plan to become pregnant or are possibly pregnant should consult a doctor. Breastfeeding women should discontinue breastfeeding or stop taking this medication as it may be passed through breast milk and pose a risk of adverse reactions for the baby. Safety and efficacy in children have not been established, and caution is required when using this medication in the pediatric population. In the elderly, the drug concentration may increase, so caution is needed during administration. In case of overdose, symptoms such as low blood pressure, palpitations, and bradycardia may occur; immediate treatment should be sought if these symptoms present themselves. Long-term use of this medication has not shown any carcinogenic effects or genotoxicity; however, if unusual symptoms occur during use, consult a healthcare professional.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and a suitable storage temperature is a cool place between 1 degree and 25 degrees. Storing in this manner will help maintain the drug's effectiveness and prevent deterioration.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.